World Health Organization. Media Centre: Epilepsy. Fact sheet N° 999, October 2012. [citado em 16.04.2013]. Disponível em: http://www.who.int/mediacentre/factsheets/fs999/en/

National Institute for Health and Clinical Excellence. Retigabine for the adjunctive treatment of partial onset seizures in epilepsy. NICE technology appraisal guidance 232. Issue date: July 2011. [citado em 19.04.2013]. Disponível em: http://www.nice.org.uk/nicemedia/live/13516/55426/55426.pdf

Treatment Guidelines from The Medical Letter®: Drugs for Epilepsy. The Medical Letter 2013 February; 11(126): 9‑18.

Ezogabine (Potiga) for Epilepsy. The Medical Letter 2012 August; 54(1397): 65‑67.

French JA, Abou‑Khalil BW, Leroy RF, Yacubian EMT, Shin P, Hall S, et al. Randomized, double‑blind, placebo‑controlled trial of ezogabine (retigabine) in partial epilepsy. Neurology 2011; 76: 1555‑1563.

Brodie MJ, Lerche H, Gil‑Nagel A, Elger C, Hall S, Shin P, et al. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy. Neurology 2010; 75: 1817‑1824.

Porter RJ, Partiot A, Sachdeo R, Nohria V, Alves WM. Randomized, multicenter, dose‑ranging trial of retigabine for partial‑onset seizures. Neurology 2007; 68: 1197‑1204.